发明名称 Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer
摘要 <p>The invention relates to a combination comprising a Bcr-Abl, c-Kit and PDGF-R tyrosine kinase inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.</p>
申请公布号 AU2007234382(A1) 申请公布日期 2007.10.11
申请号 AU20070234382 申请日期 2007.04.06
申请人 NOVARTIS AG 发明人 RICHARD WILLIAM VERSACE;PAUL W. MANLEY;RONALD RICHARD LINNARTZ;GREGORY PETER BURKE
分类号 A61K31/454;A61K31/4709;A61K31/473;A61K31/506;A61K31/553;A61K31/573;A61K31/704;A61K45/06;A61P35/00;A61P35/04 主分类号 A61K31/454
代理机构 代理人
主权项
地址